Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Depakote 500mg gastro-resistant tablets
0402030Q0BBABAB
|
Depakote (Bipolar) | Valproic acid | Central Nervous System | 39,936 |
|
Valproic acid 500mg gastro-resistant tablets
0402030Q0AAABAB
|
Valproic acid (Bipolar) | Valproic acid | Central Nervous System | 38,823 |
|
Valproic acid 250mg gastro-resistant tablets
0402030Q0AAAAAA
|
Valproic acid (Bipolar) | Valproic acid | Central Nervous System | 31,289 |
|
Depakote 250mg gastro-resistant tablets
0402030Q0BBAAAA
|
Depakote (Bipolar) | Valproic acid | Central Nervous System | 28,132 |
|
Valproic acid 500mg gastro-resistant capsules
040801020AAACAC
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 2,770 |
|
Belvo 500mg gastro-resistant tablets
0402030Q0BCABAB
|
Belvo | Valproic acid | Central Nervous System | 1,657 |
|
Belvo 250mg gastro-resistant tablets
0402030Q0BCAAAA
|
Belvo | Valproic acid | Central Nervous System | 1,350 |
|
Valproic acid 300mg gastro-resistant capsules
040801020AAABAB
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 834 |
|
Syonell 500mg gastro-resistant tablets
0402030Q0BDAAAB
|
Syonell | Valproic acid | Central Nervous System | 609 |
|
Syonell 250mg gastro-resistant tablets
0402030Q0BDABAA
|
Syonell | Valproic acid | Central Nervous System | 406 |
|
Valproic acid 150mg gastro-resistant capsules
040801020AAAAAA
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 387 |
|
Convulex 500mg gastro-resistant capsules
040801020BBACAC
|
Convulex | Valproic acid | Central Nervous System | 377 |
|
Convulex 300mg gastro-resistant capsules
040801020BBABAB
|
Convulex | Valproic acid | Central Nervous System | 345 |
|
Convulex 150mg gastro-resistant capsules
040801020BBAAAA
|
Convulex | Valproic acid | Central Nervous System | 159 |
|
Valproic acid 500mg/5ml oral liquid
040801020AAAGAG
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | 21 |
|
Depakote 125mg sprinkle gastro-resistant capsules
040801020BCACAH
|
Depakote (Epilepsy) | Valproic acid | Central Nervous System | No data available |
|
Valproic acid 125mg gastro-resistant capsules
040801020AAAHAH
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | No data available |
|
Valproic acid 250mg/5ml oral liquid
040801020AAAFAF
|
Valproic acid (Epilepsy) | Valproic acid | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.